Selinexor-based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy

Ajai Chari, Dan T. Vogl, Sundar Jagannath, Jagoda Jasielec, Thaddeus J. Unger, Andrew DeCastro, Jatin Shah, Michael Kauffman, Sharon Shacham, Andrzej Jakubowiak

Research output: Contribution to journalLetterpeer-review

9 Scopus citations
Original languageEnglish
Pages (from-to)e126-e130
JournalBritish Journal of Haematology
Issue number4
StatePublished - 1 May 2020


  • bortezomib
  • carfilomib
  • chimeric antigen receptor T cell refractory
  • multiple myeloma
  • selinexor

Cite this